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The EUCAST E.DEF9.1 standard recommends standardization of the inoculum concentration by conidium counting using a
hemocytometer rather than a spectrophotometer. In this study, we investigated whether the choice of these methods influenced
isavuconazole MICs. A blinded collection of 30 molecularly characterized azole-resistant isolates and 10 wild-type Aspergillus
fumigatus isolates was shared with four different laboratories. Additionally, each laboratory selected approximately 100 A. fu-
migatus isolates and 50 isolates each of A. flavus, A. nidulans, A. niger, and A. terreus (1,237 isolates in total). Three laboratories
(laboratories 1 to 3) used conidium counting. One laboratory standardized the inoculum using a spectrophotometer (that is, by
use of the optical density [OD]) and is referred to as the OD laboratory. Correlation coefficients, intraclass correlation coeffi-
cients, and essential agreement were calculated, and 2-log-unit differences were assessed (paired t test). TheMIC range for the
blinded collection was 0.25 to 16 mg/liter, and a 1-dilution-step difference between theMIC50 andMIC90 across the four labora-
tories was detected and a 2-dilution-step difference between the modal MICs was detected. Compared to the results for laborato-
ries 1 and 2, a significant correlation was found for the OD laboratory MIC data (correlation coefficients, 0.85 and 0.93, respec-
tively; intraclass correlation coefficients, 0.88 and 0.96, respectively). The number of mutant isolates whose MICs overlapped
those of the wild-type isolates was the lowest for the OD laboratory (14/30 [46.7%] mutant isolates), whereas the numbers were
18/30 (60%) isolates for laboratory 1, 17/30 (56.7%) isolates for laboratory 2, and 21/30 (70%) isolates for laboratory 3. For the A.
flavus, A. fumigatus, A. nidulans, A. niger, and A. terreus isolates, comparative analysis again defined the MIC distributions
from the OD laboratory to be in excellent agreement with those from laboratories 1 and 2 across all five Aspergillus spp. The
findings suggest that EUCAST testing using OD determination is an appropriate alternative for standardization of Aspergillus
inoculum concentrations.
The first EUCAST reference method for the susceptibility test-ing of conidium-forming molds was published in 2008 (1).
According to this standard, standardization of the inoculum con-
centration should be performed by conidium counting using a
hemocytometer rather than measuring turbidity using a spectro-
photometer. The reason for this recommendation was the con-
cern that the conidia of various molds vary in size and color and,
therefore, that the optical density (OD) might not predict the cell
concentration with adequate precision. Although in their study
Espinel-Ingroff and Kerkering (2) showed an acceptable predic-
tion of the inoculum concentration using a spectrophotometer
and 4 to 5 isolates of each of six differentmold species, later studies
using a greater number of isolates and species suggested the op-
posite (3–5). Indeed, one study showed that the spectrophotom-
eter method ensured an inoculum concentration that varied be-
tween 4  105 and 5  106 CFU at best when various isolates of
Aspergillus, Fusarium, and Scedosporium species were investigated
(3). Two subsequent studies also evaluating the precision of
counting, determination of the numbers of CFU, and hemocy-
tometer standardization of the fungal suspension similarly sug-
gested a significant variation of fungal suspensions prepared using
the spectrophotometer method but not when counting was ad-
opted (4, 5).
It is well accepted that inoculum size influences the MIC
achieved in any susceptibility test, and therefore, standardization
ismandatory.However, theCLSImold reference standard recom-
mends the use of inoculum standardization by a spectrophotom-
eter, similar to what both the CLSI and EUCAST recommend for
the susceptibility testing of yeasts (6–8). It is less time-consuming
to standardize the inoculum according to the optical density than
by conidium counting, and laboratories running the reference or
commercial tests for yeast are already familiar with the use of a
spectrophotometer for standardization of the inoculum concen-
tration of yeast (and bacterial) suspensions. Therefore, we inves-
tigated whether EUCAST isavuconazole MICs for a collection of
wild-type and cyp51A mutant A. fumigatus isolates tested blindly
in four laboratories were within acceptable agreement when three
laboratories followed the EUCAST standard regarding inoculum
preparation and one adopted spectrophotometric standardiza-
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tion of the inoculum. In addition, the distributions of the MICs
for the five most common species obtained by the laboratories
using counting and spectrophotometer standardization were
compared. TheMIC testing was done as part of a study generating
epidemiological cutoff values (ECOFFs) for isavuconazole and the
various Aspergillus species (9).
MATERIALS AND METHODS
Isolates. A blinded collection of 30 molecularly characterized azole-resis-
tant A. fumigatus clinical isolates and 10 wild-type A. fumigatus clinical
isolates was studied (all four laboratories tested the same blinded panel).
The mutant strains had alterations at the following common molecular
cyp51A azole resistance hot spots: G54 (n 10), TR34/L98H (n 10), and
M220 (n 10). Additionally, each laboratory selected approximately 100
A. fumigatus isolates and 50 isolates each ofA. flavus,A. nidulans,A. niger,
and A. terreus from their collections of wild-type Aspergillus isolates to be
tested for susceptibility in parallel with the blinded collection.
Quality control (QC) strains. Candida krusei ATCC 6258 and C.
parapsilosis ATCC 22019 were used as control strains. The MIC50s for C.
krusei ATCC 6258 and C. parapsilosis ATCC 22019 were as follows for the
individual laboratories: OD laboratory, 0.03mg/liter (range, 0.015 to 0.06
mg/liter) and 0.015 mg/liter (range, 0.015 mg/liter), respectively; labora-
tory 1, 0.03 mg/liter (range, 0.03 to 0.125 mg/liter) and 0.03 mg/liter
(range, 0.03mg/liter), respectively, laboratory 2, 0.03mg/liter (range, 0.03
to 0.125 mg/liter) and 0.015 mg/liter (range, 0.015 to 0.03 mg/liter), re-
spectively; and laboratory 3, 0.125 mg/liter (range, 0.06 to 0.25 mg/liter)
and 0.03 mg/liter (range, 0.03 to 0.06 mg/liter), respectively.
Susceptibility testing. Microdilution plates were made in-house at
each of the four laboratories following the EUCAST standard and using a
single batch of isavuconazole pure substance and local providers of me-
dium and microtiter plates. Three laboratories (laboratories 1 to 3) ad-
hered strictly to the EUCAST EDEF9.1 standard when standardizing the
inoculum (1). One laboratory (referred to as the OD laboratory) also
followed the EUCAST EDEF9.1 standard, with the exception that the
inoculum was standardized using a spectrophotometer, as follows. The
conidia were harvested in water with 0.1% Tween 20 and filtered through
an 11-m-pore-size filter (nylon net filters; Merck Millipore, Tullagreen,
Carrigtwohill, County Cork, Ireland) to remove hyphal fragments and
conidium clumps, generating a homogeneous suspension, and the sus-
pension was adjusted to an OD of 1. This suspension was diluted 1:10
before being used to inoculate the plates, as described in the EUCAST
EDEF9.1 standard.
Spectrophotometer. For the spectrophotometer (Densimat;
bioMérieux, France) used in this study, a linear relationship between the
OD and the McFarland scale was demonstrated, with an OD of 1 corre-
sponding to a McFarland standard of 0.5.
Statistical calculations. The correlation between the MIC results ob-
tained when the inoculum was standardized using conidium counting
and the optical density was evaluated by using Pearson’s correlation coef-
ficient (CC) and the intraclass correlation coefficient (ICC). The ICC was
expressed to a maximum value of 1, and the 95% confidence interval (CI)
is provided for ICCs. In order to approximate a normal distribution, the
MICs were transformed to log2 values. A P value of0.01 was considered
statistically significant. The ICC is a reversemeasurement of the variability
of the conidium counting values. The ICC was calculated using the for-
mula (group mean square – error mean square)/(group mean square 
errormean square) and thus has amaximum value of 1 if there is a perfect
correlation and aminimum value of1 if there is a complete absence of a
correlation. The ICC evaluates the correlation between values offering a
statistically significant difference since it takes into account the number of
cases and the absolute value of the count. The ICC is a scales analysis and
exhibits the highest statistical power for correlation studies (10). More-
over, the log2 differences between the OD and the conidium counting
methodwere calculated, and differences were assessed by use of the paired
t test. In addition, essential agreement between the OD and the conidium
counting method within 1 2-fold dilution was calculated for each lab
individually, and themeanMIC data among all three labs were calculated.
RESULTS
Overall, the isavuconazole MICs for the blinded collection of
wild-type and mutant strains generated in the four laboratories
fell within a range of 0.25 to 16 mg/liter, with a 1-dilution-step
difference between the MIC50 and MIC90 and a 2-dilution step
difference between the modal MICs being found across the four
laboratories (Fig. 1 and Table 1). The mean standard deviation
(SD) log2 difference between the MICs generated in the OD labo-
FIG 1 Number of wild-type (wt; below the x axis) and cyp51A mutant (above
the x axis) isolates of A. fumigatus strains with the indicated isavuconazole
MICs obtained using OD standardization of the inoculum in the OD labora-
tory (a) or conidium counting in laboratory 1 (b), laboratory 2 (c), and labo-
ratory 3 (d). The mutant collection included 10 mutant isolates with altera-
tions involving each of the codons G54, M220, and TR34 (TR)/L98H. Dotted
line, the recently proposed EUCAST epidemiological cutoff value for isavu-
conazole and A. fumigatus (9).
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ratory and those from laboratories 1 to 3 using conidium counting
was 0.3  1.1 and was equal to a mean  SD log2 difference
of0.3 1.2 when the data from laboratories 1 to 3 (all of which
used conidiumcounting)were compared. The paired t test did not
show significant differences (P 0.10), with the 90th percentile of
the absolute differences being 1.7 (whichmeans differences of less
than 2-fold). In comparison, the corresponding value for the three
laboratories that used the counting method was 2. The overall
essential agreement (within1 dilution) was 73% across the four
data sets (range among labs, 55% to 95%) and was not different
from the essential agreement between the data set from laborato-
ries 1 to 3, which used the counting methods (73%). The overall
Pearson correlation coefficient was 0.89 (95% confidence interval,
0.80 to 0.94; P 0.0001).
The MICs generated in one of the laboratories (laboratory 3)
that used conidium counting for standardization of the inoculum
were higher, particularly for the wild-type isolates, with MICs be-
ing2 mg/liter for 5/10 isolates, whereas MICs were not2 mg/
liter for any of the wild-type isolates tested in the other laborato-
ries (Fig. 1). Consequently, the number of mutant strains for
which the isavuconazole MIC overlapped the MIC range for the
wild-type population was greater for this laboratory, as the MICs
for 21/30 (70%) mutant strains overlapped the MIC range for the
wild-type population, in contrast to 18/30 (60%) isolates for lab-
oratory 1, 17/30 (56.7%) isolates for laboratory 2, and 14/30
(46.7%) isolates for the laboratory using OD standardization of
the inoculum. The correlation coefficient determination also
identified laboratory 3 to be an outlier (Table 1). Thus, the corre-
lation coefficient was 0.21 when the results from this laboratory
are compared to the results from the two other laboratories that
used conidium counting for inoculum standardization, and the
intraclass correlation coefficients were 0.34 and 0.35, respectively,
when the results from laboratory 3 are compared to the results
from laboratories 1 and 2 (Table 1). Similarly, when the MIC
values for the data set generated using OD standardization of the
inoculum were compared to those from laboratories 1 and 2,
which used conidium counting, significant CCs (individually,
0.85 to 0.93) and ICCs of 0.88 to 0.96 were found. However, this
was not the case when the data generated in the laboratory using
OD standardization were compared to those generated in labora-
tory 3 (Table 1). Finally, ICCs were significant for laboratories 1
and 2 and the OD laboratory (0.94; 95% CI, 0.89 to 0.96) but not
for laboratory 3 but were lower across all four laboratories (0.83;
95% CI, 0.73 to 0.90).
Subsequently, each laboratory tested a panel of routine isolates
of A. flavus, A. fumigatus, A. nidulans, A. niger, and A. terreus
(Table 2). The comparative analysis again demonstrated a good
agreement when the MICs generated in the laboratory using
OD for inoculum standardization were comparing with the
MICs from laboratories 1 and 2 using conidium counting, but
again, the MIC distributions from laboratory 3, which used
conidium counting, deviated the most across all five Aspergillus
spp. (Table 2).
DISCUSSION
It is well-known that susceptibility testing is associated with some
degree of variation, particularly when MIC results from multiple
laboratories are compared. In the multicenter study defining QC
ranges for the EUCASTmethod, individual QC strains were tested
multiple times. In that study, 3.7 to 8.3% of the EUCAST MICT
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results for voriconazole were outside a 3-dilution-step concentra-
tion range and 0 to 12% of the posaconazole MIC results were
outside a 4-dilution-step range forA. fumigatus strains, despite the
fact that QC strains are specifically selected because of their stable
susceptibility phenotypes to fit the requirements for use as QC
strains (11). Despite this, broth dilution methods remain the
“gold standard” for mold susceptibility testing.
Since the CLSI and EUCAST methods were established, many
MICs have been generated, and both organizations have estab-
lished epidemiological cutoff values that either are identical or
differ by 1 dilution for most Aspergillus antimold agents avail-
able, demonstrating that themethods generate comparable results
(9, 12–15). This is despite the differences between methods, in-
cluding the CLSI recommendation for inoculum standardization
using the OD value versus the EUCAST recommendation for in-
oculum standardization using a hemocytometer. Additionally, a
head-to-head comparative study demonstrated a high rate of
agreement between the MIC results (16). For example, the essen-
tial agreement was excellent when testing the three licensed azoles
active against molds and 245 Aspergillus isolates: 100% for itra-
conazole, 98.4% for posaconazole, and 99.6% for voriconazole
when essential agreement was assessed at2 dilutions and 99.6%
for itraconazole, 87.7% for posaconazole, and 96.3% for vori-
conazole when essential agreement was assessed at 1 dilution
(16). Although the method for inoculum standardization is only
one of the differences between theCLSI and EUCASTmethods for
the testing of molds, these observations suggest that the time-
consuming hemocytometer standardization of the inoculummay
not be critical.
The data in this study further suggest that the use of OD stan-
dardization of the inoculum suspension is an appropriate ap-
proach when testing isavuconazole using the EUCASTmethodol-
ogy. Thus, when the defined strain collection was shared and the
isolates were tested blindly in this study, a statistically significant
correlation between the data generated in the laboratory usingOD
determination and those generated in twoof the three laboratories
using conidium counting was found. In fact, the one laboratory
for which the MICs did not correlate significantly with the MICs
generated by any of the others used conidium counting, which
suggests that other factors are more important contributors to
MIC variation.Moreover, when theMIC distributions for the five
most common Aspergillus species were compared, the laboratory
with the most divergent results was again not the laboratory that
used OD for inoculum standardization but one of the three that
used conidium counting.
Apart from an acceptable interlaboratory reproducibility, the
ability of the method to discriminate between susceptible isolates
and those harboring acquired resistance mechanisms that affect
clinical efficacy is a crucial parameter when evaluating various
methodological procedures for susceptibility testing. When the
data for wild-type and mutant strains were compared for the 4
data sets generated in this study, the greatest degree of separation
between each molecular genotype (the wild type and the G54,
M220, and TR34/L98Hmutants) was observed for the data gener-
ated in the laboratory using OD for inoculum standardization.
The activity of isavuconazole against thesemutants has previously
been shown to differ, with theMICs being in the range of those for
the wild type for isolates with G54 alterations but with MICs for
TR34/L98H mutants being notably elevated (9). This pattern was
also found with the data generated using OD for inoculum stan-
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dardization, which again suggests that this is an acceptable
method for Aspergillus inoculum preparation.
Our findings suggest that the use of OD standardization results
in MIC data in agreement with those obtained by the standard
method using the conidium counting chamber and a good sepa-
ration between wild-type and mutant Aspergillus isolates when
testing the in vitro activity of isavuconazole. It is likely that this is
applicable to other antimold compounds as well. It is important,
however, to ensure proper standardization of the spectrophotom-
eter against theMcFarland standard and that the inoculum is pre-
pared with 0.1% Tween and filtered, as the OD value may other-
wise not be representative of the inoculum concentration.
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